Ayanda is a Zulu name meaning “growing and family”, both of which are important to us.  As such, our corporate strategy is built upon these two core values. We plan to develop medicinal cannabis products in conjunction and collaboration with patients, clinicians and scientists, by inviting them to work with us.

Our Vision is to be a global leader in Pharmaceutical grade Cannabis production.  Our mission is to establish an internationally recognized patient-centred approach to the development, translation and validation of novel cannabinoid therapies.

Our unique platform for clinical translation will provide patients, researchers and industry partners with a vehicle to study indications, refine formulations and optimize regulatory procedures to take novel therapies to market for the benefit of patients seeking natural therapies for chronic and acute disease.

Our in-house efforts are focused on innovation in the fields of Cannabinoid Cultivation, Production and Clinical Application. We aim to produce the highest quality, most consistent product possible to support clinical studies and exceed regulatory requirements.  Combined with our expertise in translational, patient-centred research we will provide a turn-key service to patient groups, academics and industry to develop novel products or evaluate and translate existing therapies for clinical indications.

Our Core Values Are:

• Patient-Centred Approach
• Unrelenting Integrity
• Scientific Rigour
• Quality and Consistency